Matches in Nanopublications for { ?s ?p "[The characterization of the estrogen receptor ligand-binding domain co-crystallized with agonists or antagonists provided a molecular basis to gain an insight into the regulation of estrogen receptor and, thereby, to describe the mechanism of the hormone therapy in treating breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[The characterization of the estrogen receptor ligand-binding domain co-crystallized with agonists or antagonists provided a molecular basis to gain an insight into the regulation of estrogen receptor and, thereby, to describe the mechanism of the hormone therapy in treating breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP724930.RAI5JdpSJ44IO79_zCCQNFZr3Q_FFOYClwsJPAoT0YURY130_assertion description "[The characterization of the estrogen receptor ligand-binding domain co-crystallized with agonists or antagonists provided a molecular basis to gain an insight into the regulation of estrogen receptor and, thereby, to describe the mechanism of the hormone therapy in treating breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724930.RAI5JdpSJ44IO79_zCCQNFZr3Q_FFOYClwsJPAoT0YURY130_provenance.
- NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion description "[The characterization of the estrogen receptor ligand-binding domain co-crystallized with agonists or antagonists provided a molecular basis to gain an insight into the regulation of estrogen receptor and, thereby, to describe the mechanism of the hormone therapy in treating breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_provenance.